ArticleMolecular therapy. Methods & clinical development2021

LATE-a novel sensitive cell-based assay for the study of CRISPR/Cas9-related long-term adverse treatment effects.

Dawid Głów et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.